+

DK0584368T3 - Anvendelse af og proces til fremstilling af henholdsvis en metastase-inhibitor og en celleadhæsions-inhibitor, som indeholder et antistof - Google Patents

Anvendelse af og proces til fremstilling af henholdsvis en metastase-inhibitor og en celleadhæsions-inhibitor, som indeholder et antistof

Info

Publication number
DK0584368T3
DK0584368T3 DK93904304T DK93904304T DK0584368T3 DK 0584368 T3 DK0584368 T3 DK 0584368T3 DK 93904304 T DK93904304 T DK 93904304T DK 93904304 T DK93904304 T DK 93904304T DK 0584368 T3 DK0584368 T3 DK 0584368T3
Authority
DK
Denmark
Prior art keywords
inhibitor
antibody
cell adhesion
metastasis
preparing
Prior art date
Application number
DK93904304T
Other languages
English (en)
Inventor
Jyunko Suntory Inst Fo Hashino
Shinzo Suntory Inst For Oikama
Hiroshi Suntory Inst Nakazato
Toshihiro Suntory In Nakanishi
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of DK0584368T3 publication Critical patent/DK0584368T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007Carcino-embryonic Antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK93904304T 1992-02-14 1993-02-12 Anvendelse af og proces til fremstilling af henholdsvis en metastase-inhibitor og en celleadhæsions-inhibitor, som indeholder et antistof DK0584368T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5955192 1992-02-14
PCT/JP1993/000182 WO1993016193A1 (en) 1992-02-14 1993-02-12 Cell adhesion inhibiting antibody and cell adhesion inhibitor containing the same

Publications (1)

Publication Number Publication Date
DK0584368T3 true DK0584368T3 (da) 2002-06-17

Family

ID=13116505

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93904304T DK0584368T3 (da) 1992-02-14 1993-02-12 Anvendelse af og proces til fremstilling af henholdsvis en metastase-inhibitor og en celleadhæsions-inhibitor, som indeholder et antistof

Country Status (9)

Country Link
US (1) US5648078A (da)
EP (1) EP0584368B1 (da)
JP (1) JP3483556B2 (da)
AT (1) ATE217909T1 (da)
DE (1) DE69331942T2 (da)
DK (1) DK0584368T3 (da)
ES (1) ES2177540T3 (da)
PT (1) PT584368E (da)
WO (1) WO1993016193A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004031238A2 (en) * 2002-10-03 2004-04-15 Mcgill Univeristy Antibodies and cyclic peptides which bind cea (carcinoembryonic antigen) and their use as cancer therapeutics
JP2002503462A (ja) * 1998-02-12 2002-02-05 マクギル ユニバーシティ Cea/ncaに基づいた癌分化療法
CA2798932C (en) 2010-05-11 2023-04-04 Governing Council Of The University Of Toronto The n-domain of carcinoembryonic antigen and compositions, methods and uses thereof
US9753036B2 (en) * 2014-04-29 2017-09-05 Edp Biotech Corporation Methods and compositions for screening and detecting biomarkers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348376A (en) * 1980-03-03 1982-09-07 Goldenberg Milton David Tumor localization and therapy with labeled anti-CEA antibody
JPH0811075B2 (ja) * 1982-06-30 1996-02-07 雄治 松岡 単クローン性抗cea抗体
JP2607492B2 (ja) * 1987-01-14 1997-05-07 サントリー株式会社 ヒト癌胎児性抗原
GB8800078D0 (en) * 1988-01-05 1988-02-10 Ciba Geigy Ag Novel antibodies
GB9014932D0 (en) * 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
JPH05119037A (ja) * 1991-08-08 1993-05-14 Suntory Ltd ヒト癌胎児性抗原の免疫測定法

Also Published As

Publication number Publication date
PT584368E (pt) 2002-10-31
ATE217909T1 (de) 2002-06-15
ES2177540T3 (es) 2002-12-16
EP0584368B1 (en) 2002-05-22
EP0584368A4 (en) 1996-07-03
WO1993016193A1 (en) 1993-08-19
DE69331942T2 (de) 2002-10-02
US5648078A (en) 1997-07-15
EP0584368A1 (en) 1994-03-02
DE69331942D1 (de) 2002-06-27
JP3483556B2 (ja) 2004-01-06

Similar Documents

Publication Publication Date Title
IT7924401A0 (it) Procedimento per la purificazione e coltivazione sequenziale di cristalli di silicio.
GEPI20105119B (en) Chimeric anti-cd20 antibody
ATE47711T1 (de) Biologisch aktive verbindung mit anti-prolyl endopeptidasewirkung.
DE3581514D1 (de) Film zur behandlung von halbleiterwaffeln.
NO177700C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, hydroksaminsyrebaserte kollagenaseinhibitorforbindelser, samt mellomprodukter til anvendelse i framgangsmåten
BG101966A (en) Application of 1l-agonist for the treatment of lack of urine retention
IT1229181B (it) Mezzi di trasporto per buste.
EP0982988A4 (en) IN KEY PURE ZONULIN AS A PHYSIOLOGICAL MODULATOR OF "TIGHT JUNCTIONS" IN MAMMALS
DE69630955D1 (de) Immortalisierung bzw. desimmortalisierung von zellen
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
IT8220139A0 (it) Procedimento di micro-incapsulamento, particolarmente di colture di cellule.
EP0396505A3 (en) Monoclonal antibodies specific for an immunoglobulin isotype
DK0584368T3 (da) Anvendelse af og proces til fremstilling af henholdsvis en metastase-inhibitor og en celleadhæsions-inhibitor, som indeholder et antistof
NO850027L (no) Overflateaktiv forbindelse og emulsjon inneholdende denne, samt anvendelse derav.
IT1231727B (it) Peptidi utili per la determinazione e la purificazione di anticorpi anti gamma interferone.
DE59309740D1 (de) Lyopilisierte, wirkstoffhaltige emulsion
NO875199L (no) Renin-inhibitorer.
IT8722316A0 (it) Confezione di prodotti chimici.
NO891713D0 (no) Monoklonale antistoffer til vevplasminogenaktivator (t-pa)
IT1142141B (it) Procedimento e substrato di fermentazione
FI941394A0 (fi) Peptidejä,jotka kykenevät säätelemään akrosomireaktiota
IT8125461A0 (it) Enzima terapeuticamente utile eprocedimento per la sua preparazione.
IT7926516A0 (it) Ibrido della euforbia di colore salmone e procedimento per la sua moltiplicazione vegetativa.
IT8321507A0 (it) Procedimento di preparazione fermentativa di l-leucina.
IT1127697B (it) Cassa di valvola per aerosol
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载